Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.34 USD | +0.99% | -4.06% | +1.69% |
15/05 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
14/05 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.69% | 45Cr | |
+51.84% | 6.39TCr | |
-2.26% | 4.18TCr | |
+40.01% | 4.05TCr | |
-10.22% | 2.72TCr | |
+13.28% | 2.65TCr | |
-21.49% | 1.87TCr | |
+2.76% | 1.27TCr | |
+22.02% | 1.21TCr | |
+27.58% | 1.21TCr |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Frequency Therapeutics : Names Peter Pfreundschuh as Chief Financial Officer